GlaxoSmithKline manufactures Zofran, a brand name for the generic drug Ondansetron. The drug Zofran was cleared by the U.S. Food and Drug Administration (FDA) in 1991 to help relieve nausea and excessive vomiting in patients who were undergoing chemotherapy, radiation treatments and also, surgery. Doctors also received encouragement by the drug manufacturer to prescribe Zofran for off-label use to pregnant women to help relieve serious cases of nausea. Contact a Zofran lawyer if you have concerns.
Recent studies unfortunately found that this drug originally created to help relieve medical ailments linked to serious and potentially life-threating health and medical problems in both cancer patients and in newborns.
If you believe that you or a loved one has been hurt from Zofran use, please contact our law firm today. We are currently reviewing Zofran class action claims against the drug manufacturer GlaxoSmithKline; you may receive compensation for lost wages, medical expenses and also, other damages.
2012 Glaxosmithkline Fraud Case
The drug’s original intent didn’t include expectant mothers, the drug manufacturer pleaded guilty in 2012 after facing accusations of fraud for wrongfully promoting the drug to doctors for off-label use and for paying doctors kickbacks for promising to prescribe the drug to pregnant women. The 2012 lawsuit required that the drug manufacturer pay $3 billion in federal and state penalties. Since then, parents filed two major class actions claims* on behalf of three children born with serious birth defects. Their birth defects are claimed to be linked to their mother’s use of Zofran during pregnancy.
Serious Health Problems Linked to Zofran
Zofran has been labeled a potentially dangerous drug that may cause serious birth defects in newborns and the development of potentially fatal heart problems in children and also, adult cancer patients. Newborn birth defects include:
- Cleft palate
- Cleft lip
- Low birth rate
- Club hand
- Also, club foot
- Musculoskeletal deformities
- ASD (Atrial Septal Defect)
- VSD (Ventricular Septal Defect)
- Lastly, heart murmur
Children and adult patient heart problems:
- Arrhythmia (abnormal heart rhythm)
- Lastly, torsades de Pointes (potentially fatal, abnormal heart rhythm)
Less visible heart defects and conditions are often harder to detect; also, increasing the potential of developing into severe health problems.
You should seek medical attention if you notice signs of the following symptoms in a newborn, child, adult or yourself after using Zofran:
- Rapid breathing (newborn)
- Difficulty feeding (newborn)
- Failure to thrive (newborn)
- Also, blueness in the lips
- Chest flutters
- Chest pounding
- Shortness of breath
- Lastly, fatigue